LM2I leads to CAD ubiquitination and liver cancer suppression through activation of ASS1.
Scholarly article — Journal Article / research-article
Study designOther literature / records
SubjectHuman & animal
Record checks
- Study design
- Other literature / records
- Subject
- Human & animal
- Publication year
- 2025
- Source
- doi.org
- Abstract display
- Not reproduced here
- Publication status
- Active
- Status checked
- 17 Aug 2026
- Collected
- 13 Aug 2026
- Freshness
- Current
- Review stage
- Automated
- Record status
- Published
Abstract
The abstract is not reproduced here. Please consult the original source.
MeSH
PMID 40448443
View source →